NY Atty Gen Eliot Spitzer has evidently rejected Marsh’s offer of $600 million to end his case against the broker for bid-rigging and other sins. Instead, he is seeking $750 million and a public apology from the company as the cost of settling the case.
Given that Mr. Spitzer’s former colleague is now head of Marsh, don’t be surprised to see this get worked out in gentlemanly fashion.
On MLK day
“Of all the forms of inequality, injustice in healthcare is the most shocking and inhumane.”
Rev. Dr. Martin Luther King, Jr.
Gov. Jeb Bush (R) of FL announced a proposal to enroll FL’s 2.1 million Medicaid recipients in private health plans, a sweeping change from the present program wherein the government acts as the sole administrator.
The program is designed to address FL’s rapidly growing Medicaid cost, which at $14 billion accounts for a quarter of the state budget. At present growth rates, the program will double in size, and consumption of the state’s budget, within eleven years.
Bush’s proposal, Mike Leavitt’s nomination to Sec HHS, and other recent pronouncements from the administration noted here and elsewhere are adding clarity to the picture of governmental health programs of the future. Here’s the essence –
–government as funder, not administrator
–funds based on defined contribution not defined benefit
–beginning to push responsibility for lifestyle-related diseases onto insureds
Not exactly Hillary II, but perhaps even more far-reaching.
Thanks to Andrea Lewis of Choice Medical Management in FL for pointing me to this…
Medicare will increase payments to physicians by 2.6% in 2006.
While this will likely not lead to a line out the door at the Bentley dealerships, it will impact other health care payers whose reimbursement is tied to Medicare – including most states that use Medicare as a basis for their Workers’ Comp fee schedules.
Note that 2.6% is well under the general rate of inflation. Again, providers will undoubtedly seek to recover the lost income from other payers…
In a rather stunning announcement, GM announced it’s earnings in 2005 would suffer a significant decline, due in large part to (free subscription required) GM’s increasing health care costs.
As a global competitor, GM is hampered by the US health care payment system, which is largely employer-driven. This has a direct, and very signficant, impact on its competitiveness. To quote the Times:
” G.M. is the largest automaker in the world by volume, but its profits are dwarfed by those of foreign competitors like Toyota and Nissan. The company is hampered on numerous fronts, including the obligation to pay health care and pension benefits to about a half million American retirees and their families. Competitors based in nations with socialized medical systems do not have similar retiree health care burdens. ”
By way of comparison, GM’s annual health care budget of approximately $73 BILLION is equivalent to about half of the UK’s National Health Service’s annual expenditures.
The silver lining in this funnel cloud is easily discerned – when companies the size and stature of GM are finding their earnings dragged down, and dragged down significantly, by health care costs, we are getting closer to the point where we must address our national health care cost crisis.
Health care is rapidly becoming an issue of global competitiveness.
January 28th is the date set for the First Health shareholder vote on the proposed acquisition by Coventry. With regulatory approvals out of the way, the vote should be a formality.
The last remaining obstacle was the outstanding shareholder lawsuit demanding more information about the deal, which executives get what benefits, and may even lead to a public airing of FH’s financial adviser.
The reasoning behind the lawsuit appears to be FH shareholders’s (and Coventry owners as well) objecting to FH executives’ payouts under the deal, coupled with a perception that FH may not have marketed itself effectively.
Regardless, the deal is done. The next, and much more interesting phase, will be to see what Tom McDonough, the Coventry exec tasked with managing the acquistion, does next.
The Medicare Payment Advisory Commission released its recommendations for changes to Medicare, and they aren’t just playing around at the margins.
Key recommendations include –
–instituting a pay-for-performance scheme for hospitals, doctors, and home-care facilities (no details provided…)
–extend the moratorium on building specialty hospitals for an additional 18 months, which would end the prohibition at the end of 2006
–reduce hospital reimbursement below the overall increase of the market-basket 3.3% to just 2.9%.
Hospitals will certainly breathe a bit easier with the extension of the moratorium on construction, at least those hospitals facing competition from privately-funded ambulatory surgical, cancer, and orthopedic centers.
As suggested here before, prepare for a significant change in government-funded health care programs. And, prepare for the downstream effect of these changes as providers seek to recoup lost revenue from private payers.
Consolidation in geographic areas appears to increase hospital costs, without any apparent impact on quality. The latest issue of Health Affairs includes a report on an analysis that proves what many have thought for some time – the growth of health systems (as they acquire or eliminate independent hospitals) is associated with higher costs.
Note the wording – “is associated with”, not “results in”. Not that I’m trying to be circumspect, far from it – but the study stops short of proving a definitive linkage between consolidation and increased cost.
However, the study does conclude with the statement, “This analysis suggests that consumers were worse off as a result of hospital consolidations.”
The pace of consolidation has slowed, from over 300 hospitals merged or acuired in in 1997, to just over 100 in 2002. Thus, the consolidation wave may have peaked. That does not mean the impact has; oligopolies tend to test their pricing power carefully; the increased cost noted in the article may not be the final word.
One point that goes unmentioned – in all the rhetoric surrounding the typical hospital merger/acquisition, you always hear about how joint purchasing, contracting, and integration of IT and administration is going to save money.
When? and for whom?
The newly elected government has big plans for Medicare, Medicaid, and other entitlement programs. Well, perhaps we should say not-as-big plans.
In California HealthLine (an excellent daily news source) yesterday, the following appears:
“White House officials and congressional budget leaders last week indicated that President Bush in his budget request to Congress “will try to impose firm, enforceable limits on the growth of federal benefit programs” while continuing to “give priority to military operations and domestic security over social welfare programs,” the New York Times reports.”
To those readers who have been with us since the beginning (I know, only two plus months ago…), this will come as no surprise. Quite simply, we cannot afford tax cuts, guns, and health care; and the two that appear to be winning are tax cuts and guns.
Where does that leave Medicare?
“Bush has said that his new Medicare law will hold down costs, but a 2004 actuaries report — signed by three Cabinet secretaries, including Thompson — concluded that the program’s long-term liabilities had increased by more than one-third, or $17 trillion, in a single year.” The article went on to note that Bush claimed the $500 billion Medicare Drug bill will save money by “paying for medicine that would prevent the need for expensive heart surgery”.
Sounds like pharma’s DTP (direct to presidents) campaign is working…
But seriously, it is puzzling that the federal executive and legislative branches are focused on Social Security reform when Medicare is significantly more impaired.
Business Insurance magazine notes that health care costs are now over 15% of GDP – following is an excerpt from their article on same:
” In 2003, health expenditures in the United States climbed 7.7%, to $1.7 trillion, down substantially from a 9.3% growth rate in 2002, according to the U.S. Centers for Medicare and Medicaid Services.
Still, because health costs rose much more than the overall growth in the economy, health spending accounted for a record 15.3% of the GDP in 2003, up from 14.9% in 2002.
Of the nation’s $1.7 trillion health care tab, private payers, such as health insurers and self-funded employers, paid out $913.2 billion in 2003, an increase of 8.6%.
Hospital spending, which accounts for about one-third of national health care expenditures, climbed 6.5% in 2003, down from 8.5% in 2002. Spending growth for prescription drugs slowed significantly, with costs rising 10.7% in 2003, down from 14.9% in 2002. CMS attributed the slowdown in prescription drug costs increases to several drugs losing their patent protection and lower-cost generics becoming available and the expanded use of tiered co-payment plans, which give employees a financial incentive to use lower-cost generics. ”